Abstract:Editorial Office Annals of Translational Medicine Submitted Oct 14, 2023. Accepted for publication Jan 15, 2024. Published online Apr 09, 2024. doi: 10.21037/atm-2023-22 Erratum to: Ann Transl Med 2021;9:663. This article (1) titled "Activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis" (doi: 10.21037/atm-21-1215), unfortunately, contains errors in Figure 5 and its legend, the citation of Figure 5 in the Results section and misuse of the word "mice" or "mouse" in the article. Corrections are presented below. Corrected Figure 5 and its legend In the section of Results Observation of serum and subchondral bone immunity in rat OA model HE staining observation should be corrected as follows: In normal rat, the subchondral bone cells of the knee joint were arranged in an orderly manner, number was normal, there was no fibrous tissue proliferation, and none or occasional infiltration of lymphocytes and monocytes ( Figure 5A ). In the 2-week model rat, the arrangement of knee joint subchondral osteocytes was slightly disordered, and a small amount of fibrous tissue was occasionally infiltrated with lymphocytes and monocytes ( Figure 5B ). In the 4-week model rat, knee joint subchondral osteocytes were reduced, cell arrangement was disordered, fibrous tissue formation could be seen, and some lymphocytes and monocyte infiltration were apparent ( Figure 5C ). In the 6-week model rat, knee joint subchondral bone cells were significantly reduced, cell arrangement was disordered, fibrous tissue was more than that of 4-week model rat, lymphocyte and monocyte infiltration was visibly greater than in the 4-week model rat ( Figure 5D ). In the 8-week model rat, the knee joint subchondral bone cells were significantly reduced, the cell arrangement was disordered, there was more fibrous tissue proliferation, and more visible infiltration of lymphocytes and monocytes ( Figure 5E ). Furthermore, the word "mice" or "mouse" presented in this article should be changed to "rat". The authors apologize for the oversight. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Correction: Undenatured type II collagen prevents and treats osteoarthritis and motor function degradation in T2DM patients and db/db mice.

Undenatured type II collagen prevents and treats osteoarthritis and motor function degradation in T2DM patients and db/db mice

Correction: Fan Et Al. Native Collagen II Relieves Bone Impairment Through Improving Inflammation and Oxidative Stress in Ageing Db/db Mice. Molecules 2021, 26, 4942

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Native Collagen II Relieves Bone Impairment through Improving Inflammation and Oxidative Stress in Ageing db/db Mice

[Corrigendum] Changes of Type II Collagenase Biomarkers on IL‑1β‑induced Rat Articular Chondrocytes

Corrigendum: Comparative Study of Alginate and Type I Collagen As Biomaterials for Cartilage Stem/progenitor Cells to Construct Tissue-Engineered Cartilage in Vivo

Undenatured type II collagen and its role in improving osteoarthritis

Corrigendum to “FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice”

Corrigendum: Alleviation of Synovial Inflammation of Juanbi-Tang on Collagen-Induced Arthritis and TNF-Tg Mice Model

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway

Correction: Enhancing Osteogenic Differentiation of MC3T3-E1 Cells During Inflammation Using UPPE/β-TCP/TTC Composites Via the Wnt/β-catenin Pathway

Correction: Enhancing osteogenic differentiation of MC3T3-E1 cells during inflammation using UPPE/β-TCP/TTC composites via the Wnt/β-catenin pathway.

Differences between soluble and insoluble undenatured type II collagen in improving osteoarthritis in rats and their potential mechanisms

Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice: Erratum

Corrigendum to “Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment” [Bioact. Mater. 18C (2022) 1–14]

Erratum: Human Umbilical Cord MSCs as New Cell Sources for Promoting Periodontal Regeneration in Inflammatory Periodontal Defect: Errautm.

Erratum to “Effects of daphnetin on the autophagy signaling pathway of fibroblast-like synoviocytes in rats with collagen-induced arthritis (CIA) induced by TNF-α” [Cytokine: X 1 (2019) 100015]

Erratum to activation of the extracellular-signal-regulated kinase (ERK)/c-Jun N-terminal kinase (JNK) signal pathway and osteogenic factors in subchondral bone of patients with knee osteoarthritis

Undenatured Type II Collagen Ameliorates Inflammatory Responses and Articular Cartilage Damage in the Rat Model of Osteoarthritis

Corrigendum: Beneficial Effects and Toxicity Studies of Xian-ling-gu-bao on Bone Metabolism in Ovariectomized Rats